Moxetumomab Pasudotox-tdfk and Revefenacin inhalation
Determining the interaction of Moxetumomab Pasudotox-tdfk and Revefenacin inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: revefenacin
Brand name: Yupelri
Synonyms: Revefenacin (inhalation), Revefenacin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Reversol
- Moxetumomab Pasudotox-tdfk-Revesta
- Moxetumomab Pasudotox-tdfk-Revestive
- Moxetumomab Pasudotox-tdfk-Revex
- Moxetumomab Pasudotox-tdfk-ReVia
- Moxetumomab Pasudotox-tdfk-Revitalose-C-1000
- Revefenacin inhalation-Moxetumomab pasudotox-tdfk Intravenous
- Revefenacin inhalation-Moxifloxacin
- Revefenacin inhalation-Moxifloxacin (Systemic)
- Revefenacin inhalation-Moxifloxacin Hydrochloride
- Revefenacin inhalation-Moxifloxacin Injection
- Revefenacin inhalation-Moxifloxacin Intravenous